UNITED CAPITAL FINANCIAL ADVISORS, LLC - PDL BIOPHARMA INC ownership

Quarter-by-quarter ownership
UNITED CAPITAL FINANCIAL ADVISORS, LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2021$3,760,0000.0%37,0000.0%0.02%0.0%
Q2 2021$3,760,000
+9300.0%
37,0000.0%0.02%
Q3 2020$40,000
+2.6%
37,0000.0%0.00%
Q2 2020$39,0000.0%37,0000.0%0.00%
Q1 2020$39,000
-2.5%
37,0000.0%0.00%
Q4 2019$40,000
+11.1%
37,0000.0%0.00%
Q3 2019$36,000
-5.3%
37,0000.0%0.00%
Q2 2019$38,00037,0000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
SMH CAPITAL ADVISORS INC 12,804,000$12,636,00021.66%
Context Partners Fund, L.P. 7,175,000$7,034,0004.09%
Context Capital Management, LLC 7,175,000$7,034,0004.09%
Pinnacle Holdings, LLC 3,260,000$3,217,213,0001.11%
Venator Capital Management Ltd. 2,000,000$1,960,0000.98%
LINDEN ADVISORS LP 26,617,000$26,292,0000.80%
WHITEBOX ADVISORS LLC 21,681,000$21,396,0000.65%
WOLVERINE ASSET MANAGEMENT LLC 16,852,000$16,518,0000.19%
OAKTREE CAPITAL MANAGEMENT LP 4,695,000$4,657,0000.06%
AQR Arbitrage LLC 3,150,000$3,124,0000.04%
View complete list of PDL BIOPHARMA INC shareholders